To be honest, I miss those days... $PYPL (+0,02%) Being a shareholder without getting hate on a regular basis doesn't feel right somehow, how do you feel about that? 🤔

Into 2025 + Happy New Year + Rewind 2024 is live + Class action against Paypal

And here we go again with fresh news. Once again, I wish you all a happy new year. Let it be another year rich in returns.

• The Rewind for 2024 is live

Don't forget to take a look at the Rewind for 2024. How did you do and what did 2024 bring you? Also take the chance to get 500 coins and take part in a competition where you can win up to €250. It's very easy and is explained in this getquin post by CEO Christian.

https://app.getquin.com/en/activity/IchLDXGEEp

• US YouTubers prepare class action lawsuit against PayPal $PYPL (+0,02%)
  prepare

After the affiliate fraud allegations before Christmas, the investigative video by YouTuber MegaLag now also has legal consequences: An influencer lawyer from the US is now preparing a class action lawsuit against the browser extension Honey, which could put parent company PayPal in a tight spot.

https://www.computerbase.de/news/netzpolitik/nach-betrugsvorwuerfen-gegen-honey-us-youtuber-bereiten-sammelklage-gegen-paypal-vor.90876/

Monday: Stock market dates, economic data, quarterly figures

Stock market holiday in Sweden, Finland and Russia

• ex-dividend of individual stocks

Endesa EUR 0.41

JPMorgan Chase USD 1.25

• Economic data

09:45 IT: Purchasing Managers' Index/PMI non-manufacturing December FORECAST: 50.0 previous: 49.2

09:50 FR: Purchasing Managers' Index/PMI non-manufacturing (2nd release) December PROGNOSE: 48.2 1: Published: 48.2 Previous: 46.9 Total Purchasing Managers' Index (2nd release) PROGNOSE: 46.7 1: Published: 46.7 Previous: 45.9

09:55 DE: Purchasing Managers' Index/PMI non-manufacturing (2nd release) December PROGNOSE: 51.0 1: Published: 51.0 Previous: 49.3 Total Purchasing Managers' Index (2nd release) PROGNOSE: 47.8 1: Published: 47.8 Previous: 47.2

10:00 EU: Purchasing Managers' Index/PMI non-manufacturing euro area (2nd release) December PROGNOSE: 51.4 1: Published: 51.4 Previous: 49.5 Total Purchasing Managers' Index (2nd release) PROGNOSE: 49.5 1: Published: 49.5 Previous: 48.3

10:30 UK: Purchasing Managers' Index/PMI non-manufacturing (2nd release) December PROGNOSIS: N/A 1st release: 51.4 previous: 50.4

14:00 DE: Consumer prices (final) December PROGNOSE: +0.3% yoy/+2.4% yoy previous: -0.2% yoy/+2.2% yoy HICP PROGNOSE: +0.4% yoy/+2.6% yoy previous: -0.7% yoy/+2.4% yoy

15:45 US: Purchasing Managers' Index/PMI Service (2nd release) December FORECAST: 57.1 1st release: 58.5 previous: 56.1

16:00 US: Industrial New Orders November FORECAST: -0.3% yoy previous: +0.2% yoy

Hello community,

I came across an interesting video.

In a nutshell, it's about this:

• Paypal has bought Honey. This is an extension (add-on) for Chrome.
• Influencers advertise Honey with their ref-link
• Honey replaces the reflink with its own to generate profit.
• Influencer gets nothing
• Discount codes do not exist

I have sold my profit ... unfortunately earlier but still at a profit. How credible the video is for one or the other is up to you.

https://www.youtube.com/watch?v=vc4yL3YTwWk

$OCGN (-0,81%) sold and directly invested in $PYPL (+0,02%) directly.

Let's see what happens.

First tranche from PayPal $PYPL (+0,02%) purchased 💸

After much deliberation, I opened my first position in PayPal today. I believe in the long-term potential of the company, especially in the area of digital payments. The current valuation seemed attractive to me after the recent market weakness.

Let's see how the investment develops - I'm excited! What do you think of PayPal $PYPL (+0,02%) ? Are you already invested or are you still watching the stock?

Why I will soon be investing 5 digits in $PYPL (+0,02%) and see 300% potential

After a lengthy analysis, I have decided to soon make a 5-digit investment in $PYPL (+0,02%) (ticker: PYPL) soon. Here are my reasons and why I see a price potential of up to 300%:

1. undervaluation & turnaround opportunity

$PYPL (+0,02%) has fallen sharply in recent years and is currently trading well below its all-time high. The price/earnings ratio (P/E ratio) is favorable by historical standards. Many negative factors appear to have already been priced in.

2. solid business model

$PYPL (+0,02%) is one of the market leaders in online payments with a global user base of over 400 million active accounts. The trend towards cashless payments and e-commerce will continue to grow in importance in the coming years.

3. growth opportunities through new business areas

$PYPL (+0,02%) is expanding into new areas such as cryptocurrencies, "buy now, pay later" services and digital wallets. This offers enormous growth potential, especially in emerging markets.

4. strong cash flows & share buybacks

The company consistently generates strong cash flows and invests aggressively in share buybacks, which should increase the value per share in the long term.

5. analyst estimates & price targets

Many analysts have recently revised their price targets for $PYPL (+0,02%) upwards despite the current uncertainties. Some see potential of up to 200 % and more, which supports my assessment.

Risk assessment: Of course there are risks such as competitive pressure, regulatory uncertainties and economic weaknesses. However, I am convinced that PayPal can achieve a successful turnaround in the long term.

Conclusion:

With a long-term investment horizon and the current valuation, I see $PYPL (+0,02%) as a strong investment opportunity with up to 300 % potential. I therefore plan to enter the share at a 5-digit level soon. 🚀📈

How do you see PayPal? Invested or wait-and-see?

$TMDX (-0,75%) - Company presentation part 2

Why $TMDX (-0,75%) could be an opportunity - reasons and concerns

Positive:

• $TMDX (-0,75%) Is a demand-driven business. Selling products that people need usually means that the products sell themselves. In any economic climate, there are people waiting for organs.

• The business model of $TMDX (-0,75%) is very robust. When an organization buys an organ, it keeps the console. When it uses the organ, it immediately buys a new organ to replenish the console. If an organization wants to use the NOP service for transport only, the contracts usually provide for OCS to be used in some way, whether to house/monitor the organ during transport or to purchase OCS outright to house the organ once the organization receives it.

• The entire transplant industry is massively underutilized

• Why $TMDX (-0,75%) wins in transplants:

$TMDX (-0,75%) Could easily become a monopoly (especially NOP) or expand their lead. You start in a niche, dominate it and keep expanding.

• $TMDX (-0,75%) the NOP logistics command center:

• Unique competitive advantage:

Concerns:

• $TMDX Has only recently become profitable and is inconsistent. You only reached profitability a year ago.

Net income:

Q4 2023: 4 million $

Q1 2024: 12.2 million $

Q2 2024: 12.2 million dollars

Q3 2024: 4.2 million USD

• In the last four quarters, costs have risen faster than revenue. This is something you don't want to see in a company that has recently become profitable.

• $TMDX (-0,75%) Has about $330m in cash, but still has about $178m in net debt

• $TMDX (-0,75%) would be a candidate for loss absorption. The share price has fallen sharply for half a year. For people who are still holding the share with a book loss, a sale now would be a good opportunity to offset this with profits from this year.

• The sentiment at $TMDX is at a multi-year low. Having just posted their first QoQ decline (although still up 64% y/y), the aesthetics of their rising sales, which has led to a 900% return on share price in 4.5 years, is ruined. If $TMDX (-0,75%) delivers another disappointing quarter, it could leave a nasty taste in Wall Street's mouth in the long run, regardless of how well the business might be doing - much like $PYPL (+0,02%) and $SOFI (+0,19%)

• $TMDX has a very asset-heavy business model. They own a fleet of aircraft, they own hubs that store OCS consoles and maintain aircraft, they own vehicles for ground transportation. All these assets are not cheap to maintain. This is a very complex logistics network that needs to be utilized/utilized, as opposed to e.g. $SHOP (-0,38%) , $PLTR (-1,37%) and Co, whose entire business is based on software.

• The whole business depends on the generosity of others. Without donors, there is no business. It is not the case that $TMDX (-0,75%) can ramp up/scale organ production to higher numbers. I could see NOP and renting out this fleet in the future, for medical purposes only, could be a great way to expand the monopoly on transplants.

• has a very niche business. There are only a limited number of people looking for a new organ. This will lead to some restrictions on business growth unless they expand at some point.

Bottom line:

I think $TMDX (-0,75%) could be a good buy now. The current weakness in the numbers is fundamentally not due to weakness in the business, but it is being sold off heavily as if it is. Down 50% because the transplant industry as a whole is down ? Because more was spent this quarter on expanding the business for 2025 ? Because the QoQ increase could not be sustained due to aircraft maintenance ?

I will consider getting in, what stops me at the moment is that you can't control the supply, but if you continue to develop the technology and others also use your services, the growth should be able to be sustained.

Share gifts at Trade Republic.

Does anyone know whether if you give away €25 shares several times, you have the chance to win the €10,000 several times?

The first time I won a whopping €2 in effing $PYPL (+0,02%) won. 😅

Have you tried it yet and what did you get?

Chart technology from the picture book V

PayPal

The safer, easier way to pay.

$PYPL (+0,02%)